You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sorafenib

Showing 51 - 75 of 320
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • HAIC
  • +8 more
  • Quanzhou, Fujian, China
  • +1 more
Jan 26, 2023

Hepatocellular Carcinoma, Hepatoma, Liver Cell Carcinoma Trial in United States (DEB-TACE, Sorafenib)

Terminated
Has Results
  • Hepatocellular Carcinoma
  • +2 more
  • DEB-TACE
  • Sorafenib
  • Birmingham, Alabama
  • +5 more
Jan 25, 2021

Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer Trial in Tampa (Lenvatinib, Sorafenib, Cabozantinib)

Terminated
Has Results
  • Thyroid Cancer
  • +5 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jul 12, 2021

Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (Tepotinib 300 mg, Tepotinib 500 mg, Tepotinib 1000 mg)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Tepotinib 300 mg
  • +4 more
  • Beijing, Beijing, China
  • +42 more
Aug 22, 2022

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • TACE
  • +8 more
  • Quanzhou, Fujian, China
  • +3 more
Jan 29, 2023

Liver Metastasis, Cancer Trial in Toronto (Sorafenib)

Completed
  • Liver Metastasis
  • Cancer
  • Sorafenib
  • Toronto, Ontario, Canada
    University Health Network
Sep 8, 2020

Hepatocellular Carcinoma Trial in Worldwide (PDR001, Sorafenib)

Completed
  • Hepatocellular Carcinoma
  • Detroit, Michigan
  • +8 more
Dec 16, 2020

Lung Cancer Trial in New Haven, Houston (Erlotinib, AZD6244, MK-2206)

Completed
Has Results
  • Lung Cancer
  • New Haven, Connecticut
  • +1 more
Dec 14, 2021

Hepatocellular Cancer Trial in Boston (Sorafenib, radiofrequency ablation)

Completed
Has Results
  • Hepatocellular Cancer
  • Sorafenib
  • radiofrequency ablation
  • Boston, Massachusetts
  • +1 more
Sep 10, 2020

Sarcoma Trial in Los Angeles (sorafenib, Ifosfamide)

Terminated
Has Results
  • Sarcoma
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jul 29, 2020

Unresectable Hepatocellular Carcinoma, Portal Vein Thrombosis Trial in Hangzhou (SBRT+TACE+Sorafenib, Sorafenib)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Portal Vein Thrombosis
  • SBRT+TACE+Sorafenib
  • Sorafenib
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Jun 15, 2020

Advanced Hepatocellular Carcinoma (HCC) Trial in Beijing (camrelizumab;Rivoceranib, Rivoceranib, Sorafenib)

Enrolling by invitation
  • Advanced Hepatocellular Carcinoma (HCC)
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Oct 21, 2021

Cancer, Advanced Solid Tumors Trial in Amsterdam (Sunitinib, Sorafenib, Erlotinib)

Completed
  • Cancer
  • Advanced Solid Tumors
  • Amsterdam, Netherlands
    VUMedical Center
Apr 14, 2021

Hepatocellular Carcinoma Trial in Birmingham, Cleveland, Houston (Carotuximab (TRC105), Sorafenib)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Carotuximab (TRC105)
  • Sorafenib
  • Birmingham, Alabama
  • +2 more
Jul 2, 2020

Carcinoma, Hepatocellular, Secondary Trial in Hong Kong (Sorafenib, Capecitabine, Oxaliplatin)

Completed
  • Carcinoma, Hepatocellular
  • Secondary
  • Sorafenib
  • +2 more
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Apr 9, 2020

Hepatocellular Carcinoma Trial in Guangzhou (Sorafenib, Transarterial chemoembolization)

Recruiting
  • Hepatocellular Carcinoma
  • Sorafenib
  • Transarterial chemoembolization
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Mar 23, 2020

Hepatocellular Carcinoma Trial in Worldwide (TheraSphere®, Sorafenib)

Terminated
Has Results
  • Hepatocellular Carcinoma
  • TheraSphere®
  • Sorafenib
  • Chicago, Illinois
  • +18 more
Apr 19, 2021

HepatoCellular Carcinoma, Unresectable HepatoCellular Carcinoma, Liver Cancer Trial in Tampa (Stereotactic Body Radiation

Withdrawn
  • HepatoCellular Carcinoma
  • +2 more
  • Stereotactic Body Radiation Therapy (SBRT)
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 3, 2020

Hepatocellular Cancer Trial in Boston (Leucovorin, Fluorouracil, Oxaliplatin)

Completed
Has Results
  • Hepatocellular Cancer
  • Boston, Massachusetts
  • +2 more
Apr 21, 2020

Carcinoma, Hepatocellular, Neuroendocrine Tumors Trial in Aarhus (Sorafenib, Radiofrequency ablation (RFA) or surgery,

Completed
  • Carcinoma, Hepatocellular
  • Neuroendocrine Tumors
  • Sorafenib
  • +3 more
  • Aarhus, Aarhus C, Denmark
    Department of Hepatology and Gastroenterology
Apr 27, 2021

Advanced Cancer Trial in Houston (Bevacizumab, Sorafenib, Erlotinib)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 27, 2020

Solid Tumors, Advanced Cancer Trial in Houston (Anastrozole, Bevacizumab, Everolimus)

Completed
  • Solid Tumors
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 20, 2021

Carcinoma, Hepatocellular Trial in Worldwide (Atezolizumab, Bevacizumab, Sorafenib)

Active, not recruiting
Has Results
  • Carcinoma, Hepatocellular
  • Phoenix, Arizona
  • +118 more
Jun 14, 2022

AML, FLT3-ITD Mutation Trial in Hong Kong (Sorafenib, Omacetaxine Mepesuccinate Injection)

Completed
  • AML
  • FLT3-ITD Mutation
  • Sorafenib
  • Omacetaxine Mepesuccinate Injection
  • Hong Kong, Hong Kong
    The University of Hong Kong
Mar 26, 2020

Leukemia, Acute Myeloid Leukemia Trial in Houston (Selinexor, Sorafenib)

Completed
Has Results
  • Leukemia
  • Acute Myeloid Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 18, 2020